All Policies Include Enhanced COVID-19 Cover
Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30
Coronavirus FAQs
Questions about cover for coronavirus? Read our FAQs and find out what our policies can do for you. If you would like to contact us, please note we are currently only available 09:00 to 17:30 Monday to Friday due to reduced operational capacity. Thank you.
14 July 2015 08:47
Breast cancer patients could benefit from having progesterone added to their treatment, data suggests
Breast cancer outlooks could be improved by having a widely available female hormone added to treatments, research suggests.
Progesterone, which is involved in signals between cell molecules, has been found to hold back tumour growth.
Cancer Research UK predicts adding the hormone to treatments could benefit half of breast cancer patients.
Breakthrough
The fact that breast cancer patients whose tumours have progesterone receptors - molecules sensitive to the hormone - often have a better outlook has puzzled scientists for a number of decades.
But experts at the Cancer Research UK Cambridge Institute believe they have finally come up with the answer.
They used cutting-edge technology to identify the crucial role that progesterone receptors play in breast cancer.
The progesterone receptor was found to "talk to" another receptor sensitive to the hormone oestrogen, which fuels breast cancer in a large number of cases.
This applies a brake on the oestrogen receptor's ability to stimulate tumours.
Travel plans
Around 50,000 new cases of breast cancer are diagnosed each year in the UK.
But a diagnosis does not mean life has to stop.
Breast cancer travel insurance gives patients the peace of mind they need to explore the world.
Clinical trial
The researchers claim half of the 50,000 new patients could potentially benefit from their discovery.
Dr Jason Carroll, one of the authors of the study, says the finding provides a strong case for a clinical trial to investigate the potential benefit of adding progesterone to drugs that target the oestrogen receptor.
He claims doing so could improve treatment for the majority of hormone-driven breast cancers.
Drugs such as Tamoxifen are commonly used to treat oestrogen-sensitive breast cancers. They block the hormone's receptor.
In future, they could be combined with progesterone to mount a two-pronged attack on the disease.
The findings of the new study were reported in the Nature journal.
21 September 2020
Take a trip to the world's top tanneries.
[more...]
Learn more about the Land of the Rising Sun's most famous culinary export.
09 September 2020
Get a slice of the action in Napoli, the pizza capital of the world.
Get way ahead with your getaway plans with our top five handy tips for planning a holiday in 2021...
02 September 2020
Many international borders may have reopened, but is air travel safe during the coronavirus pandemic? The answer may surprise you.
26 August 2020
Learn more about the government's advice on travel corridors and see the list of countries where you can travel back from without self-isolating.
Plan your next getaway while reducing the risk of catching and transmitting coronavirus, by following our simple advice.
09 March 2020
Move over hot cross buns and chocolate eggs, there's a whole world of Easter treats out there. Here are some alternative Easter foods from around the world.
Forget egg hunts and bunnies, Easter's done a little bit differently in these corners of the world. Here five alternative Easter celebrations.
28 February 2020
Keep your carbon footprint in check and travel green with our eco-friendly travel tips.
25 February 2020
For true carefree travel, decide on a destination that's kinder to the planet...